M
Marc E. Wolf
Researcher at Heidelberg University
Publications - 60
Citations - 1506
Marc E. Wolf is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Deep brain stimulation. The author has an hindex of 17, co-authored 57 publications receiving 1079 citations.
Papers
More filters
Journal ArticleDOI
The ASCOD phenotyping of ischemic stroke (Updated ASCO Phenotyping).
Pierre Amarenco,Julien Bogousslavsky,Louis R. Caplan,Geoffrey A. Donnan,Marc E. Wolf,M.G. Hennerici +5 more
TL;DR: ASCOD captures and weights the overlap between all underlying diseases present in ischemic stroke patients, and adds a cardiogenic stroke pattern using neuroimaging.
Journal ArticleDOI
Gender Differences in Acute Ischemic Stroke Etiology, Stroke Patterns and Response to Thrombolysis
Alex Förster,Achim Gass,Rolf Kern,Marc E. Wolf,Caroline Ottomeyer,Katrin Zohsel,Michael G. Hennerici,Kristina Szabo +7 more
TL;DR: Differences of stroke lesion patterns in genders are paralleled by differences in etiology and risk factor profiles (women, cardioembolism; men, large and small vessel disease).
Journal ArticleDOI
Monogenic variants in dystonia: an exome-wide sequencing study.
Michael Zech,Robert Jech,Sylvia Boesch,Matej Skorvanek,Sandrina Weber,Matias Wagner,Chen Zhao,Angela Jochim,Ján Necpál,Yasemin Dincer,Katharina Vill,Felix Distelmaier,Malgorzata Stoklosa,Martin Krenn,Martin Krenn,Stephan Grunwald,Stephan Grunwald,Tobias Bock-Bierbaum,Tobias Bock-Bierbaum,Anna Fečíková,Petra Havránková,Jan Roth,Iva Příhodová,Miriam Adamovičová,Olga Ulmanová,Karel Bechyně,Pavlína Danhofer,Branislav Veselý,Vladimír Haň,Petra Pavelekova,Zuzana Gdovinova,Tobias Mantel,Tobias Meindl,Alexandra Sitzberger,Sebastian Schröder,Astrid Blaschek,Timo Roser,Michaela Bonfert,Edda Haberlandt,Barbara Plecko,Birgit Leineweber,Steffen Berweck,Thomas Herberhold,Berthold Langguth,Jana Švantnerová,Michal Minár,Gonzalo Alonso Ramos-Rivera,Monica H. Wojcik,Monica H. Wojcik,Sander Pajusalu,Sander Pajusalu,Sander Pajusalu,Katrin Õunap,Katrin Õunap,Ulrich A. Schatz,Laura Pölsler,Ivan Milenkovic,Franco Laccone,Veronika Pilshofer,Roberto Colombo,Steffi Patzer,Arcangela Iuso,Julia Vera,Mónica Troncoso,Fang Fang,Holger Prokisch,Friederike Wilbert,Matthias Eckenweiler,Elisabeth Graf,Dominik S. Westphal,Korbinian M. Riedhammer,Theresa Brunet,Bader Alhaddad,Riccardo Berutti,Tim M. Strom,Martin Hecht,Matthias Baumann,Marc E. Wolf,Aida Telegrafi,Richard E. Person,Francisca Millan Zamora,Lindsay B. Henderson,David Weise,Thomas Musacchio,Jens Volkmann,Anna Szuto,Jessica Becker,Kirsten Cremer,Thomas Sycha,Fritz Zimprich,V. Kraus,Christine Makowski,Pedro Gonzalez-Alegre,Tanya Bardakjian,Laurie J. Ozelius,Annalisa Vetro,Renzo Guerrini,Esther M. Maier,Ingo Borggraefe,Alice Kuster,Saskia B. Wortmann,Saskia B. Wortmann,Saskia B. Wortmann,Annette Hackenberg,Robert Steinfeld,Birgit Assmann,Christian Staufner,Thomas Opladen,Evžen Růžička,Ronald D. Cohn,David A. Dyment,Wendy K. Chung,Hartmut Engels,Andres O. Ceballos-Baumann,Rafał Płoski,Oliver Daumke,Oliver Daumke,Bernhard Haslinger,Volker Mall,Konrad Oexle,Juliane Winkelmann +120 more
TL;DR: The role of monogenic variants across the range of dystonic disorders is determined, providing guidance for the introduction of personalised care strategies and fostering follow-up pathophysiological explorations.
Journal ArticleDOI
Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure
TL;DR: In this article, the authors describe the clinical manifestations and the concerning management of patients with cranial venous sinus thrombosis following first exposure to the COVID-19 vaccine AstraZeneca.
Journal ArticleDOI
How to identify stroke mimics in patients eligible for intravenous thrombolysis
TL;DR: Compared demographics, symptoms, complications, and outcome of patients with stroke mimics (SM) to those with acute infarction, which might be helpful in deciding which patients should undergo acute stroke MRI to rule out SM, facilitate treatment decisions, and reduce the risk of unnecessary therapy.